Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

RPHM

Reneo Pharmaceuticals Inc

Last Close
May 16 • 10:59AM ET
1.61
Dollar change
+0.01
Percentage change
0.62 		%
Held by: VTI IWM VXF IBB IWO VTWO IWC SBIO AVSC VTWG Scroll to Statements
IndexRUT P/E- EPS (ttm)-2.17 Insider Own33.43% Shs Outstand33.42M Perf Week-13.44%
Market Cap53.81M Forward P/E- EPS next Y-0.38 Insider Trans3.85% Shs Float22.25M Perf Month-9.04%
Income-70.71M PEG- EPS next Q-0.16 Inst Own55.76% Short Float13.81% Perf Quarter-3.59%
Sales0.00M P/S- EPS this Y67.06% Inst Trans0.31% Short Ratio11.06 Perf Half Y-74.61%
Book/sh2.43 P/B0.66 EPS next Y54.22% ROA-77.06% Short Interest3.07M Perf Year-79.85%
Cash/sh2.48 P/C0.65 EPS next 5Y- ROE-84.01% 52W Range0.98 - 9.45 Perf YTD0.62%
Dividend Est.- P/FCF- EPS past 5Y-50.29% ROI-86.42% 52W High-82.96% Beta0.21
Dividend TTM- Quick Ratio29.82 Sales past 5Y0.00% Gross Margin- 52W Low64.27% ATR (14)0.09
Dividend Ex-Date- Current Ratio29.82 EPS Y/Y TTM1.00% Oper. Margin0.00% RSI (14)41.10 Volatility8.15% 5.66%
Employees8 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom3.33 Target Price1.35
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q58.22% Payout- Rel Volume1.00 Prev Close1.60
Sales Surprise- EPS Surprise42.75% Sales Q/Q- EarningsMay 07 BMO Avg Volume277.79K Price1.61
SMA20-5.75% SMA50-4.46% SMA200-61.68% Trades Volume74,170 Change0.62%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Downgrade Leerink Partners Outperform → Market Perform
Dec-15-23Downgrade Jefferies Buy → Hold
Dec-15-23Downgrade H.C. Wainwright Buy → Neutral $30 → $1.50
Dec-14-23Downgrade William Blair Outperform → Mkt Perform
Dec-14-23Downgrade Robert W. Baird Outperform → Neutral $28 → $3
Dec-14-23Downgrade Piper Sandler Overweight → Neutral $25 → $4
Dec-14-23Downgrade Ladenburg Thalmann Buy → Neutral
Dec-14-23Downgrade BofA Securities Buy → Underperform $23 → $1.45
Nov-15-23Initiated William Blair Outperform $35.55
Aug-28-23Initiated H.C. Wainwright Buy $30
Show Previous Ratings
Today 10:01AM
Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing
(MT Newswires)
May-13-24 08:25AM
Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise
(MT Newswires) -12.15%
07:35AM
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
(GlobeNewswire)
May-07-24 01:53PM
RPHM Stock Earnings: Reneo Pharmaceuticals Beats EPS for Q1 2024
(InvestorPlace)
07:35AM
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
(GlobeNewswire)
12:53PM Loading…
Mar-28-24 12:53PM
RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023
(InvestorPlace)
07:35AM
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
(GlobeNewswire)
Mar-25-24 07:00AM
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
(GlobeNewswire)
Dec-21-23 04:13PM
These Stocks under $10 Are Poised To Explode
(Insider Monkey)
Dec-15-23 10:19AM
Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study
(Zacks) +5.97%
Dec-14-23 12:35PM
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
(Benzinga) -82.71%
09:05AM
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
(GlobeNewswire)
Nov-13-23 05:04PM
Reneo Pharmaceuticals Inc (RPHM) Reports Q3 2023 Financial Results
(GuruFocus.com)
07:35AM
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
(GlobeNewswire)
Nov-02-23 07:50AM
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
07:50AM Loading…
Oct-25-23 07:50AM
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
(GlobeNewswire)
Oct-20-23 01:22PM
12 Best Performing Biotech Stocks in 2023
(Insider Monkey) -5.76%
Oct-09-23 07:50AM
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
(GlobeNewswire)
Oct-06-23 08:30AM
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
(GlobeNewswire) +11.47%
Aug-29-23 07:35AM
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire) +5.30%
Aug-10-23 07:35AM
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
(GlobeNewswire)
07:31AM
Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) stock price dropped 10% last week; private equity firms would not be happy
(Simply Wall St.)
Jul-27-23 11:19AM
Bank of America Says These 2 Stocks Could Double Your Money Heres Why They Could Rally
(TipRanks) +17.59%
Jun-30-23 08:25AM
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
(GlobeNewswire)
Jun-26-23 08:25AM
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
(GlobeNewswire)
Jun-15-23 12:44PM
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
(GlobeNewswire)
May-31-23 10:38AM
Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
(GlobeNewswire)
08:00AM
Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
(GlobeNewswire)
May-21-23 07:42PM
Insiders Pour $1 Million Each Into These 2 Strong Buy Stocks Heres Why Wall Street Thinks They Could Double (or More)
(TipRanks)
May-12-23 06:00PM
MP Materials, Pitney Bowes See Activist Investor Action
(Barrons.com)
07:45AM Loading…
May-11-23 07:45AM
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
(GlobeNewswire) +6.02%
May-03-23 11:36PM
Reneo Announces Pricing of Public Offering of Common Stock
(GlobeNewswire)
04:01PM
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
(GlobeNewswire)
Mar-27-23 07:30AM
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
(GlobeNewswire)
Mar-14-23 07:30AM
Reneo Pharmaceuticals Achieves Target Enrollment in the Pivotal STRIDE Study of Mavodelpar (REN001) in Primary Mitochondrial Myopathies
(GlobeNewswire)
Mar-09-23 08:00AM
Reneo Pharmaceuticals to Present Preclinical Mavodelpar (REN001) Data at the Society for Inherited Metabolic Disorders Annual Meeting 2023
(GlobeNewswire)
Mar-03-23 06:07AM
Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) largest shareholders are private equity firms who were rewarded as market cap surged US$33m last week
(Simply Wall St.)
Feb-02-23 07:35AM
Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference
(GlobeNewswire)
Jan-31-23 07:35AM
Reneo Pharmaceuticals Receives Fast Track Designation from the FDA for Mavodelpar (REN001) in a Genotype of Long-Chain Fatty Acid Oxidation Disorder (LC-FAOD)
(GlobeNewswire)
Dec-04-22 07:12AM
Is Reneo Pharmaceuticals (NASDAQ:RPHM) In A Good Position To Deliver On Growth Plans?
(Simply Wall St.)
Nov-08-22 07:35AM
Reneo Pharmaceuticals Reports Third Quarter 2022 Financial Results
(GlobeNewswire)
Nov-03-22 08:00AM
Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
(GlobeNewswire)
Sep-14-22 06:02AM
Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) biggest owners are private equity firms who got richer after stock soared 25% last week
(Simply Wall St.) +8.24%
Sep-06-22 08:35AM
Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
(GlobeNewswire)
Aug-29-22 07:35AM
Reneo Pharmaceuticals Announces Poster Presentations at the International Network for Fatty Acid Oxidation Research and Management Annual Meeting
(GlobeNewswire)
Aug-09-22 08:00AM
Reneo Pharmaceuticals Reports Second Quarter 2022 Financial Results
(GlobeNewswire) -5.26%
Aug-04-22 09:10AM
Insiders who bought in the last 12 months lose an additional US$83k as Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) drops to US$57m
(Simply Wall St.) +14.89%
Aug-02-22 07:30AM
Reneo Pharmaceuticals Appoints Roshawn Blunt to its Board of Directors
(GlobeNewswire) -15.92%
Jul-26-22 09:52AM
Reneo Pharmaceuticals Says Metabolic Disorder Program To Enter Next Stage Of Development
(Benzinga)
07:30AM
Reneo Pharmaceuticals Reports Positive Results from REN001 Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Study and Provides Additional Development Updates
(GlobeNewswire)
Jul-11-22 08:00AM
Reneo Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) -6.84%
Jun-30-22 08:00AM
Reneo Pharmaceuticals to Present Data from Phase 1 REN001 Limb Immobilization Study at the 17th International Congress on Neuromuscular Diseases (ICNMD 2022)
(GlobeNewswire) +13.73%
Jun-20-22 08:33AM
Is Reneo Pharmaceuticals (NASDAQ:RPHM) In A Good Position To Invest In Growth?
(Simply Wall St.)
May-10-22 04:05PM
Reneo Pharmaceuticals Reports First Quarter 2022 Financial Results
(GlobeNewswire) +9.09%
Mar-23-22 04:05PM
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
(GlobeNewswire)
Mar-07-22 08:30AM
Reneo Pharmaceuticals Announces Senior Leadership Promotions
(GlobeNewswire)
Feb-02-22 08:00AM
Reneo Pharmaceuticals to Participate in SVB Leerink Virtual Global Healthcare Conference
(GlobeNewswire) -8.93%
Jan-24-22 08:00AM
Reneo Pharmaceuticals Announces Changes to its Board of Directors
(GlobeNewswire)
Jan-10-22 11:55AM
We're Not Very Worried About Reneo Pharmaceuticals' (NASDAQ:RPHM) Cash Burn Rate
(Simply Wall St.)
Dec-22-21 11:04AM
3 Strong Buy Stocks Under $10 With Triple-Digit Upside Potential
(TipRanks) +15.28%
Nov-11-21 04:05PM
Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results
(GlobeNewswire) +9.08%
Nov-01-21 04:05PM
Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
(GlobeNewswire) +6.71%
Oct-14-21 08:00AM
Reneo Pharmaceuticals Announces Notice of Allowance for Patent Application on REN001
(GlobeNewswire)
Oct-11-21 02:35PM
Here's What Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) Shareholder Ownership Structure Looks Like
(Simply Wall St.)
08:00AM
Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer
(GlobeNewswire)
Sep-28-21 08:26AM
Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial Myopathies
(GlobeNewswire)
Sep-09-21 09:12AM
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire) -5.69%
Aug-11-21 05:55AM
Reneo Pharmaceuticals Reports Second Quarter 2021 Financial Results
(GlobeNewswire)
Jul-28-21 08:00AM
Reneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study
(GlobeNewswire)
Jul-12-21 09:30AM
We're Not Very Worried About Reneo Pharmaceuticals' (NASDAQ:RPHM) Cash Burn Rate
(Simply Wall St.) +5.29%
Jul-09-21 08:00AM
Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction
(GlobeNewswire)
Jul-07-21 08:00AM
Reneo Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
(GlobeNewswire)
Jun-29-21 08:00AM
Reneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
(GlobeNewswire)
May-20-21 06:00AM
Reneo Pharmaceuticals Reports First Quarter 2021 Financial Results
(GlobeNewswire) +6.34%
May-19-21 06:00AM
Reneo Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
(GlobeNewswire) +5.62%
Apr-13-21 08:14AM
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
(Benzinga)
Apr-09-21 12:32PM
Biotech Stocks: 14 Things to Know as the VECT Stock IPO and RPHM Stock IPO Begin Trading Today
(InvestorPlace)
Apr-08-21 09:42PM
Reneo Pharmaceuticals Announces Pricing of Initial Public Offering
(GlobeNewswire)
Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leonard Braden Michael10% OwnerMay 14 '24Buy1.54414,281639,5782,672,194May 16 08:58 AM
Hall AshleyChief Development OfficerAug 28 '23Option Exercise1.8015,62528,12555,225Aug 29 05:04 PM
Hall AshleyChief Development OfficerAug 28 '23Sale6.2815,62598,05839,600Aug 29 05:04 PM
Novo Holdings A/S10% OwnerJun 23 '23Sale7.10100,000709,7403,330,337Jun 23 07:15 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.